| Announce Date | 02/11/2026 |
| EPS Normalized Actual | $1.63 (Beat by $0.52) |
| EPS GAAP Actual | $1.63 (Beat by $0.52) |
| Revenue Actual | $0.46225B |
| Revenue Surprise | Beat by $462.25M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $4.44666 |
| EPS GAAP Estimate | $4.44666 |
| Revenue Estimate | $0.608998591B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 21.1874 | 4.12 | 20.13207 | 22.45786 | 2 |
| Dec 2029 | 18.72956 | 4.66 | 17.56012 | 19.74073 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | -0.5 | -2.20318 | 0.46225B | -3.22% | 17.67M |
| FQ2 2025 (Jun 2025) | 1.21 | -0.52474 | 0.406615B | -5.56% | 72.94M |
| FQ1 2025 (Mar 2025) | 2.52 | 2.52 | 0.496331B | -6.34% | 496.33M |
| FQ4 2024 (Dec 2024) | 1.06 | 1.06 | 0.468171B | 100% | 468.17M |
| FQ3 2024 (Sep 2024) | 2.05 | 2.05 | 0.477155B | 6.37% | 477.16M |
| FQ2 2024 (Jun 2024) | 1.44 | 1.44 | 0.429214B | 0.84% | 429.21M |
| FQ1 2024 (Mar 2024) | 2.53 | 2.53 | 0.527788B | -5.84% | 527.79M |
| FQ4 2023 (Dec 2023) | 0 | 0 | 0B | NAN% | 0M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
4.44666
Consensus Revenue Estimates
0.608998591B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 3.62771 | -- | 3.51862 | 3.76855 | 1 |
| FQ3 2027 (Sep 2027) | 3.13774 | -- | 3.04338 | 3.25956 | 1 |
| FQ2 2027 (Jun 2027) | 1.51704 | -- | 1.47142 | 1.57594 | 1 |
| FQ1 2027 (Mar 2027) | 3.44868 | -- | 3.34497 | 3.58257 | 1 |
| FQ4 2026 (Oct 2026) | 4.80209 | -- | 4.45985 | 5.07911 | 1 |
| FQ3 2026 (Jul 2026) | 2.35224 | 121.26 | 2.1846 | 2.48794 | 1 |
| FQ2 2026 (Jun 2026) | 1.82019 | 33.52 | 1.70758 | 1.92816 | 1 |
| FQ1 2026 (Mar 2026) | 4.44666 | 43.33 | 4.26041 | 4.72191 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.52B | -- | 0.5B | 0.53B | 2 |
| FQ3 2027 (Sep 2027) | 0.51B | -- | 0.49B | 0.52B | 2 |
| FQ2 2027 (Jun 2027) | 0.43B | -- | 0.42B | 0.45B | 2 |
| FQ1 2027 (Mar 2027) | 0.54B | -- | 0.53B | 0.56B | 2 |
| FQ4 2026 (Oct 2026) | 0.6B | -- | 0.57B | 0.63B | 2 |
| FQ3 2026 (Jul 2026) | 0.49B | 5.66 | 0.46B | 0.51B | 2 |
| FQ2 2026 (Jun 2026) | 0.37B | -9.89 | 0.35B | 0.39B | 2 |
| FQ1 2026 (Mar 2026) | 0.61B | 18.5 | 0.59B | 0.64B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
5
EPS # of Misses
2
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
0
Revenue # of in-lines
1
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.70318 | -0.5 | -2.20318 | 440.64% |
| FQ2 2025 (Jun 2025) | 1.73474 | 1.21 | -0.52474 | -43.37% |
| FQ1 2025 (Mar 2025) | 2.52 | 2.52 | 100% | |
| FQ4 2024 (Dec 2024) | 1.06 | 1.06 | 100% | |
| FQ3 2024 (Sep 2024) | 2.05 | 2.05 | 100% | |
| FQ2 2024 (Jun 2024) | 1.44 | 1.44 | 100% | |
| FQ1 2024 (Mar 2024) | 2.53 | 2.53 | 100% | |
| FQ4 2023 (Dec 2023) | 0 | 0 | NAN% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.44B | $0.46B | $17.67M | 3.82% |
| FQ2 2025 (Jun 2025) | $0.33B | $0.41B | $72.94M | 17.94% |
| FQ1 2025 (Mar 2025) | $0B | $0.5B | $496.33M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.47B | $468.17M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.48B | $477.16M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.43B | $429.21M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.53B | $527.79M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |